Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study

Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial

(2012) Michel Delforge et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Shifts in the Therapeutic Paradigm for Patients Newly Diagnosed with Multiple Myeloma: Maintenance Therapy and Overall Survival

(2011) Antonio Palumbo et al.   CLINICAL CANCER RESEARCH

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

(2011) Philippe Moreau et al.   LANCET ONCOLOGY

Management of treatment-emergent peripheral neuropathy in multiple myeloma

(2011) P G Richardson et al.   LEUKEMIA

Chemotherapy-induced neuropathic pain

(2011) Paul Farquhar-Smith   Current Opinion in Supportive and Palliative Care

Cancer Symptom Clusters: Old Concept But New Data

(2010) Jordanka Kirkova et al.   American Journal of Hospice & Palliative Medicine

Enhancing research in regenerative medicine

(2010) D. A. Williams et al.   BLOOD

Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer

(2010) Karis K.F. Cheng et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

(2010) Maria-Victoria Mateos et al.   JOURNAL OF CLINICAL ONCOLOGY

Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners

(2010) Alex Molassiotis et al.   PSYCHO-ONCOLOGY

What changes in health-related quality of life matter to multiple myeloma patients? A prospective study

(2009) Ann K. Kvam et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

(2009) Cyrille Hulin et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

(2009) M A Dimopoulos et al.   LEUKEMIA

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE